According to a Phase 3 trial published in The Lancet Diabetes & Endocrinology, a once-weekly combination of semaglutide and ...

Studies with SGLT2 inhibitors in people with type 1 diabetes have reported modest reductions in HbA1c (0.2% to 0.4%), modest weight loss (2-3 kg) and the ability to reduce background bolus and ...

The feature is used for bolus insulin dosing, said the company. According to the nonprofit organization Beyond Type 1, bolus insulin is a type of insulin taken to prevent glucose spikes after meals.

Hellman J, Hartvig NV, Kaas A, Møller JB, Sørensen MR, Jendle J. Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 ...

In COMBINE 3, for which Novo Nordisk released top line results in January 2024, 679 people with type 2 diabetes inadequately controlled on basal-bolus insulin therapy were randomized to receive ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes Omnipod GO™ (Photo: Business Wire) ...

Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.